CClinicalTrials.gg
CompletedNCT00572520Updated Jul 5, 2018

Effectiveness of Behavioral Treatments for Obesity and Major Depression in Women

An interventional study of Weight loss treatment and Behavior therapy for depression in Depression and Obesity, sponsored by University of Massachusetts, Worcester. Completed at 1 site in United States. Open to female participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-07-05.

Sponsored by University of Massachusetts, Worcester · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
161
Allocation
Randomized
Ages
21 Years to 65 Years
Sex
Female
01

Study summary

This study will compare the effectiveness of two weight loss programs, one supplemented with health education and the other supplemented with behavioral counseling, in treating women who are depressed and overweight.

Read the detailed description

Obesity is one of the most alarming current health problems in the United States, with 31% percent of the population considered obese. Previous studies have shown that there is a higher incidence of depression in people who are overweight. It is not known whether depression causes obesity or vice versa, but the association may stem from the stigma of obesity or from the appetite and weight gain caused by depressive symptoms. With the increased risk of cardiovascular and other life-threatening diseases from obesity, promotion of healthful habits is important. Providing the motivational skills to adhere to these habits is also crucial, especially in people who are both overweight and depressed. This study will compare the effectiveness of two weight loss programs, one supplemented with health education and the other supplemented with behavioral counseling, in treating women who are depressed and overweight.

Participants in this 2-year study will be divided into one of two treatment groups: one group will address weight loss and depression via nutrition, exercise, and health education and the other group will address weight loss and depression via nutrition, exercise, and behavioral counseling. Participants receiving health education will learn about women's health topics and receive tips on staying healthy and preventing disease. Participants receiving behavioral counseling will learn about depression and links between activity and mood. They will also be asked to keep a diary of moods and activities. Participants in both treatment groups will undergo the same schedule of study visits and assessments. A baseline visit will include blood tests; measurements of height, weight, waist size, and blood pressure; and completion of questionnaires about depression, eating habits, and physical activity. Next, over a 3-week period, participants will receive three phone calls asking about food intake from the previous day. In the first 6 months of the study, there will be a total of 26 weekly treatment visits. These visits will consist of ten 1-hour sessions with a counselor and sixteen 90-minute sessions with a dietician. During the next 6 months, participants will continue to meet with their dieticians monthly for a total of 6 visits and will receive monthly phone calls from their counselor. Quaterly phone calls with their counselor will continue in the second year of the study. There will be three check-in appointments similar to the baseline assessment, occurring at Month 6 and Years 1 and 2.

02

Conditions studied

  • Depression
  • Obesity

Keywords

  • Depressive Disorder
  • Weight Loss
  • Behavioral Treatment
  • Behavior Therapy
  • Randomized Clinical Trial
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 161 is above the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Massachusetts, Worcester is the lead sponsor of 288 studies on the registry; 54 are open to participants now.

Of its 25 completed or terminated interventional studies of FDA-regulated products, 18 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Meets DSM-IV criteria for major depressive disorder
  • Score of 12 to 24 on Hamilton Depression Rating Scale (HDRS)
  • Body mass index (BMI) of 30 to 40 kg

Exclusion criteria

Exclusion Criteria:

  • Plans to move out of the area during the study
  • Current smoker
  • Diagnosis of bipolar disorder, a psychotic disorder, bulimia, or post-traumatic stress disorder
  • Meets criteria for severe depression (HDRS score greater than 24)
  • Diagnosis of type 1 or 2 diabetes
  • Plans to have bariatric surgery during the study
  • No access to a telephone
  • Unable to walk unaided or unable to walk 1/4 mile without stopping
  • Does not have written clearance from primary care physician for physical activity
  • Presence of a condition that precludes dietary changes (e.g., ulcerative colitis, Crohn's disease, active diverticulitis, renal disease)
  • Presence of medical conditions likely to limit lifespan
  • Taking prescription weight loss medications
  • Initiation of anti-depressant medication within the 3 months prior to study entry
  • Taking mood stabilizers, antipsychotic medication, or medications known to affect appetite and/or weight (e.g., corticosteroids)
  • Reports active suicidal ideation via SCID interview, a score of 3 on item 24 of the HDRS (active suicidal ideation), or determined to have suicidal potential by clinical staff
  • Psychiatric hospitalization in the 12 months prior to study entry
  • Currently receiving psychotherapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
161 participants (actual)

Study arms

  • Active comparator
    1

    Evidence-based behavioral weight loss treatment with health education counseling

    Behavioral: Weight loss treatment · Behavioral: Health education counseling

  • Experimental
    2

    Evidence-based behavioral weight loss treatment with brief behavior therapy for depression

    Behavioral: Weight loss treatment · Behavioral: Behavior therapy for depression

Interventions

  • BehavioralWeight loss treatment

    Over 2 years, this treatment involves a total of 26 group visits and 10 individual visits with a health education counselor. Group visits, led by a registered dietitian and a licensed exercise physiologist, will target diet and physical activity.

  • BehavioralBehavior therapy for depression

    Behavior therapy for depression will be delivered by a trained behavior therapist. Participants receiving behavioral counseling will learn about depression, links between activity and mood, and will be asked to keep a diary of moods and activities.

  • BehavioralHealth education counseling

    Health education counseling will be delivered by a trained health education counselor. Participants receiving health education will learn about women's health topics and receive tips on staying healthy and preventing disease.

06

What researchers measure

Primary outcomes

  1. Change in body weight and the trend in body weight over time

    Time frame: Measured at Month 6 and Years 1 and 2

Secondary outcomes

  1. Change in depression, physical activity, diet (daily caloric intake), psychosocial variables (anhedonia, exercise self-efficacy, disinhibited eating, quality of life), and cardiovascular risk factors (blood pressure, serum lipids, C-reactive protein)

    Time frame: Measured at Year 2

  2. Effect of potential mediators (adherence, depression, general and physical activity, caloric intake) on weight change

    Time frame: Measured at Year 2

07

Study locations

1 site
  • University of Massachusetts Medical School
    Worcester, Massachusetts 01655, United States
08

References and documents

Publications

  • Schneider KL, Bodenlos JS, Ma Y, Olendzki B, Oleski J, Merriam P, Crawford S, Ockene IS, Pagoto SL. Design and methods for a randomized clinical trial treating comorbid obesity and major depressive disorder. BMC Psychiatry. 2008 Sep 15;8:77. doi: 10.1186/1471-244X-8-77. PubMed 18793398 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00572520
Lead sponsor
University of Massachusetts, Worcester
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
Dec 13, 2007
Start date
Jul 2007
Primary completion
Apr 2012
Completion
Apr 2012
Last update
Jul 5, 2018

Study contacts

Sherry L. Pagoto, PhD
principal investigator · University of Massachusetts, Worcester

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion